News | EP Lab | February 01, 2017

Scientists Keep Human Hearts Alive in Lab to Track Abnormal Beats

Researchers ‘reanimate’ parts of human hearts to find elusive sources of arrhythmia

Ohio State, Wexner Medical Center, keeping human hearts alive, track abnormal beats, reanimate, Vadim Fedorov

Part of a donated human heart is reanimated and recorded with four high-definition optic cameras in a laboratory at The Ohio State University Wexner Medical Center. Researchers keep the heart tissue alive to look for the causes of irregular heartbeats in cases of persistent atrial fibrillation. Image courtesy of The Ohio State University Wexner Medical Center.

February 1, 2017 — Researchers have developed a technique that allows them to revive parts of human hearts in the laboratory for up to 12 hours while they search for hidden sources of irregular heartbeats.

“It’s amazing. You can see the heart start beating again, which gives us an opportunity to study it with high-speed, high-tech equipment,” said Vadim Fedorov, Ph.D., a biologist who developed the technique at The Ohio State University Wexner Medical Center. “This allows us to see the heart in 3-D and search for sources of irregular beats that we’ve never been able to find.”

The hearts are donated by transplant patients who are receiving new hearts. Scientists take the top portions, known as the atria, and place them in a dish surrounded by four high-speed optical cameras. They then reanimate the tissue and inject it with a special dye that detects electrical signals.

“Normal imaging techniques give us one to two hundred recordings of the heart,” said Fedorov. “These cameras are able to give us 40,000 recordings, all in 3-D.”

The images allow experts to more clearly map the heart and find new areas in which to perform ablations, a procedure during which tiny cuts or burns are made to form scar tissue on the heart. The scar tissue can help disrupt the electrical circuitry of the heart and stop irregular beats.

Knowing exactly where to ablate the small areas of the heart can be challenging, especially in patients who have persistent atrial fibrillation. Their hearts beat erratically 24 hours per day, which can lead to stroke or heart failure.

“This will allow us to map the heart more completely and eventually may help us personalize our procedures according to each patient’s individual needs,” said John Hummel, M.D., director of clinical electrophysiology research at Ohio State Wexner Medical Center. “While it’s still in the early stages, the work Dr. Fedorov is doing with human heart tissue is the kind of thing that will make pivotal changes in our ability to manage patients’ diseases in the coming years.”

For more information: www.wexnermedical.osu.edu

Related Content

The study used cadaver hearts that were images with contrast enhanced MRI and the images used to create a 3-D computation model of the electrical activation in the heart and how it was influenced by adenosine and ablation. Find more images in the original article

News | Atrial Fibrillation | October 08, 2020
October 8, 2020 – People who suffer from persistent atrial fibrillation in the heart may find relief from a new treat
The TactiFlex PAF investigational device exemption (IDE) study will evaluate he investigational TactiFlex Ablation Catheter, Sensor Enabled (SE) to treat people suffering from paroxysmal atrial fibrillation (PAF). 

The TactiFlex PAF investigational device exemption (IDE) study will evaluate he investigational TactiFlex Ablation Catheter, Sensor Enabled (SE) to treat people suffering from paroxysmal atrial fibrillation (PAF). 

News | Atrial Fibrillation | August 04, 2020
August 4, 2020 — Abbott announced the first enrollments in the TactiFlex PAF  investigational device exemption (IDE)
PREDICT-AF trial showed first time there is extensive extracellular matrix remodeling. #HRS2020 #Heartrhythm2020. Marilyn Fornell
News | Atrial Fibrillation | May 19, 2020
May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the
Results of the Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study at HRS 2020. #HRS2020 #Heartrhythm2020,
News | Atrial Fibrillation | May 19, 2020
May 19, 2020 — Atrial disease has been implicated in embolic stroke of undetermined source (ESUS) and a late-breaking
Contact Force Sensing Catheter Improved Outcomes in Persistent Atrial Fibrillation Ablation. #HRS2020 #heartrhythm2020
News | Atrial Fibrillation | May 13, 2020
May 13, 2020 — The PRECEPT study testing the use of the Biosense Webster Thermocool Smarttouch SF Catheter for the tr
The Swiss-AF study shows High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation | May 08, 2020
May 8, 2020 – A new clinical study found that patients with...
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation | May 08, 2020
May 8, 2020 — Positive 12-month results were announced today from the...
The first-in-human results show positive results for Medtronic's pulsed field ablation in safety and efficiency. #Heartrhythm2020 #HRS2020 #HRS20
News | Atrial Fibrillation | May 08, 2020
May 8, 2020 — New clinical trial reveals the first-in-human results for paroxysmal or persistent atrial fibrillation
POPULAR TAVR trial Shows Oral Anticoagulants Alone in atrial fibrillation  (AF) Patients Reduces Bleeding Post TAVR, transcatheter aortic valve replacement. #ACC20 #ACC2020
News | Atrial Fibrillation | March 29, 2020
March 29, 2020 — Patients with atrial fibrillation (AF) who took oral anticoagulants alone after undergoing transcath